Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN D KRANT

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1023165172
CMS profile
227303
Location
PETERBOROUGH, NH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$72,418.01

155 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
AbbVie Inc. $67,585.44 72
Novartis Pharmaceuticals Corporation $2,174.36 11
Horizon Therapeutics plc $1,730.56 21
Amgen Inc. $450.34 26
E.R. Squibb & Sons, L.L.C. $140.51 3
GlaxoSmithKline, LLC. $78.36 4
UCB, Inc. $65.34 4
Lilly USA, LLC $53.56 4
Janssen Biotech, Inc. $43.79 3
Radius Health, Inc. $42.67 3
PFIZER INC. $28.72 2
Endo Pharmaceuticals Inc. $24.36 2

Page 2 of 4; records 51–100 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JONATHAN D KRANT

NPI 1023165172 · CMS profile ID 227303

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

PETERBOROUGH, NH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1023165172?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JONATHAN D KRANT, NPI 1023165172, CMS profile ID 227303. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1023165172?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JONATHAN D KRANT, NPI 1023165172, CMS profile ID 227303. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1023165172?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JONATHAN D KRANT, NPI 1023165172, CMS profile ID 227303, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1023165172?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

155 matching records · $72,418.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 155 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 155.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $1,500.0009/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721960023 CMS
Amgen Inc. $12.0309/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741403103 CMS
AbbVie Inc. $1,500.0009/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721960015 CMS
Radius Health, Inc. $15.2109/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746285487 CMS
Amgen Inc. $18.0009/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741145947 CMS
Horizon Therapeutics plc $12.9609/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412593 CMS
AbbVie Inc. $1,500.0009/03/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721960011 CMS
Lilly USA, LLC $13.1709/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728506777 CMS
AbbVie Inc. $1,500.0008/31/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721960007 CMS
AbbVie Inc. $11.7708/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721960003 CMS
Amgen Inc. $10.2508/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741145945 CMS
AbbVie Inc. $15.0008/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959999 CMS
AbbVie Inc. $1,500.0008/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959995 CMS
AbbVie Inc. $1,500.0008/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959991 CMS
PFIZER INC. $14.5108/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743288277 CMS
Amgen Inc. $13.7408/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741403101 CMS
Horizon Therapeutics plc $13.4308/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412589 CMS
Horizon Therapeutics plc $10.0008/18/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412591 CMS
AbbVie Inc. $1,500.0008/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959983 CMS
AbbVie Inc. $1,500.0008/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959987 CMS
Janssen Biotech, Inc. $12.8808/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719219565 CMS
Lilly USA, LLC $15.2008/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728506775 CMS
GlaxoSmithKline, LLC. $14.5508/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738533545 CMS
AbbVie Inc. $1,500.0007/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959973 CMS
AbbVie Inc. $1,500.0007/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959977 CMS
AbbVie Inc. $1,500.0007/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959980 CMS
Horizon Therapeutics plc $1,400.0007/21/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412587 CMS
Horizon Therapeutics plc $12.2707/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412585 CMS
GlaxoSmithKline, LLC. $30.0007/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738613667 CMS
Horizon Therapeutics plc $13.8007/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412583 CMS
Endo Pharmaceuticals Inc. $13.0007/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736530831 CMS
Amgen Inc. $10.7907/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741403099 CMS
Radius Health, Inc. $12.0807/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746285467 CMS
Horizon Therapeutics plc $9.9606/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412581 CMS
Amgen Inc. $9.1105/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741145941 CMS
Novartis Pharmaceuticals Corporation $2,020.0005/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725982655 CMS
AbbVie Inc. $13.7705/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959969 CMS
Amgen Inc. $13.2905/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741403097 CMS
UCB, Inc. $12.3105/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746057525 CMS
AbbVie Inc. $24.9505/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959965 CMS
Amgen Inc. $16.1405/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741403095 CMS
Horizon Therapeutics plc $12.4905/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412579 CMS
AbbVie Inc. $1,500.0005/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959961 CMS
Horizon Therapeutics plc $13.8704/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721412577 CMS
Amgen Inc. $14.7703/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741145937 CMS
AbbVie Inc. $1,500.0003/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959957 CMS
AbbVie Inc. $22.0003/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959949 CMS
AbbVie Inc. $17.0203/12/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959953 CMS
Novartis Pharmaceuticals Corporation $7.6803/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725982701 CMS
AbbVie Inc. $1,500.0003/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721959941 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $74,294.96 200
PY2020 $72,418.01 155
PY2021 $58,546.06 98
PY2022 $60,121.72 109
PY2023 $48,164.17 126
PY2024 $10,932.38 47
PY2025 $3,340.86 48

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $15,132.90 8
PY2020 Recipient $1,314.00 1
PY2020 Principal investigator $89,811.00 21
PY2019 Recipient $14,468.00 1
PY2019 Principal investigator $50,164.14 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $524.88 12/31/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period No dispute reported 06/30/2026 792386699
Principal investigator 1 ABBVIE INC. $230.00 06/22/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1) No dispute reported 06/30/2026 792386693
Principal investigator 1 ABBVIE INC. $2,669.38 05/25/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1) No dispute reported 06/30/2026 792386687
Principal investigator 1 ABBVIE INC. $2,372.38 03/24/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1) No dispute reported 06/30/2026 792386681
Principal investigator 1 ABBVIE INC. $4,811.76 02/25/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1) No dispute reported 06/30/2026 792386675
Principal investigator 1 Eli Lilly and Company $1,704.00 02/09/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 819448377
Principal investigator 1 ABBVIE INC. $2,735.00 01/12/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A Phase 2 Study to Investigate the Safety and Efficacy of ABBV-105 Given Alone or in Combination with Upadacitinib (ABBV-599 Combination) with a Background of Conventional Synthetic DMARDs in Subjects with Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs No dispute reported 06/30/2026 792386669
Principal investigator 1 Eli Lilly and Company $85.50 01/11/2021 Covered Recipient Teaching Hospital
MARIETTA MEMORIAL HOSPITAL
A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 819448723